Biotech Company Focus: MabVax Therapeutics (NASDAQ: MBVX) By bakerbrent36 Posted September 16, 2016 In SCN Daily News Show 0 bakerbrent36 Recent PostsBiotech Company Focus: MabVax Therapeutics (NASDAQ: MBVX)CEO Interview: Richard Schumacher of PBIO w/ TheStreet.com Analyst John PersinosBiotech Company Focus: PixarBio - CEO Interview